Navigation Links
Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
Date:5/3/2012

THE WOODLANDS, Texas, May 3, 2012 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months ended March 31, 2012.

"We continue to make excellent progress in our clinical-development stage programs and preclinical pipeline.  Our Phase 2b study of LX4211 in patients with type 2 diabetes has completed enrollment and is on track to obtain top-line data by mid-year," said Dr. Arthur T. Sands, president and chief executive officer of Lexicon.  "In addition, in the first quarter of 2012, we initiated Phase 2 studies of LX1033 in patients with diarrhea-predominant irritable bowel syndrome (IBS-d) and of LX1032 in patients with ulcerative colitis, and we launched a Phase 1-2 proof-of-concept study of LX7101 in glaucoma patients.  We look forward to obtaining data from these and our other ongoing studies and continuing the advancement of our clinical pipeline."

Key Progress in Clinical Pipeline

  • Lexicon completed enrollment in the ongoing 12-week Phase 2b study of LX4211, a dual inhibitor of sodium-glucose cotransporters 1 and 2, in patients with type 2 diabetes.  Top-line data from this study are anticipated by mid-year.
  • Lexicon is proceeding with preparations for Phase 3 registrational trials of telotristat etiprate (LX1032), an inhibitor of tryptophan hydroxylase that reduces peripheral serotonin production without affecting brain serotonin levels, in patients with carcinoid syndrome.  Lexicon als
    '/>"/>

    • SOURCE Lexicon Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Lexicon to Provide First Quarter 2012 Financial Results
    2. Lexicon Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference
    3. Lexicon Pharmaceuticals to Present at the RBC Healthcare Conference
    4. Lexicon to Report Fourth Quarter and Year End 2011 Financial Results on February 22, 2012
    5. Lexicon Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
    6. Lexicon Announces Commencement of Rights Offering to Stockholders
    7. Lexicon to Present LX4211 Clinical and Preclinical Data at Diabetes Conference
    8. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results
    9. Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2011 Financial Results
    10. Lexicon Presents LX4211 Clinical Data at European Association for the Study of Diabetes Annual Meeting
    11. Lexicon Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/23/2013)... , May 23, 2013  Spring Bank Pharmaceuticals, Inc., ... of viral infections, today announced that it has initiated ... its investigational, once daily, oral therapy for the treatment ... HCV-infected patients and is designed to assess both the ... is a first-in-class drug for the treatment of chronic ...
    (Date:5/23/2013)... Israel , May 23, 2013 ... BrainTech Israel 2013 , Israel,s 1 ... on October 14 th -15 th in ... most innovative city in the world by the ... Nation." BrainTech Israel 2013 will showcase the latest ...
    (Date:5/23/2013)... , May 23, 2013 ... announced today that the prize for ,Best Novel Idea, ... and Medical Emergency Teams International Conference, hosted this year ... was awarded to a clinical research team studying the ... California Hospital in Los Angeles . ...
    Breaking Medicine Technology:Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 2Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 3Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 4
    ... (CRL) has invested in a low-dose, state-of-the-art CT machine ... Minnesota.  This advanced diagnostic system will help physicians reach ... care with a radiation dose up to 40% lower ... "The addition of the GE Healthcare Brightspeed Elite CT ...
    ... ECRI Institute ®, an independent ... improving patient care, today announces the launch of its ... to ECRI Institute,s SELECTplus™ healthcare technology advisory service. The ... intelligence to help hospitals and health systems select and ...
    Cached Medicine Technology:Consulting Radiologists, Ltd. Announces Addition of a Low Dose Advanced Computed Tomography (CT) System 2ECRI Institute Launches Market Analytics Tool to Help Hospitals Make More Informed Capital Purchasing Decisions 2ECRI Institute Launches Market Analytics Tool to Help Hospitals Make More Informed Capital Purchasing Decisions 3
    (Date:5/23/2013)... On April 29th, 2013, UV Technologies issued ... H7N9 cases and deaths. The headline read, " UV Technologies, ... in Northern Hemisphere as Available Daylight Increases .” In fact, ... , Quoting Kevin McGuire, president of UV Technologies, "The ... in the spring and leaves changing in the fall. The ...
    (Date:5/23/2013)... Cheap Concert Tickets announces that Paul ... at stadiums throughout North America. This well known ticket ... concert tickets to help McCartney fans see Sir Paul live ... states that she is also offering the customer appreciation code ... a baby boomer, she is also a huge McCartney fan ...
    (Date:5/23/2013)... 23 (HealthDay News) -- The sensation of itching is ... back to a small molecule released in the spinal ... Researchers say this molecule, known as natriuretic polypeptide ... central nervous system. Ultimately, this signal is experienced as ... mice are similar, the researchers concluded that a similar ...
    (Date:5/23/2013)... By Dennis Thompson HealthDay Reporter , , THURSDAY, ... soda can damage teeth as badly as methamphetamine or ... at it side-to-side with ,meth mouth, or ,coke mouth, ... of damage more or less the same," said Dr. ... Temple University School of Dentistry in Philadelphia. Methamphetamine, ...
    (Date:5/23/2013)... virus isolated from a person who died from H7N9 ... infect and be transmitted between ferrets. Ferrets are often ... efficient transmission of influenza virus between ferrets can provide ... occur in people. The research was supported, in part, ... part of the National Institutes of Health. , The ...
    Breaking Medicine News(10 mins):Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 2Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 3Health News:Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle 2Health News:Got an Itch? Mouse Study May Help Explain Why 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 3Health News:Ferrets, pigs susceptible to H7N9 avian influenza virus 2
    ... Researchers at the Mayo Clinic campus in Florida ... form of dementia that affects the brain areas associated with personality, ... of the American Journal of Human Genetics , ... progranulin and sortilin they say might open new avenues ...
    ... has filed an Investigational New Drug (IND) application with the ... Phase I safety trials to test NSI-189, its first small ... a proprietary new chemical entity discovered by Neuralstem that stimulates ... brain that is believed to be involved in depression. ...
    ... and Ergonomics Society has just released the newest volume ... annual series. Volume 6 reflects editor Douglas H. ... of expertise that exists in the Society and the ... we know about specific areas of human factors/ergonomicsstate of ...
    ... HealthDay Reporter , WEDNESDAY, Nov. 17 (HealthDay ... nerves has a striking effect on lowering blood pressure ... trying multiple drugs, Australian researchers report. Although this ... six months -- the authors believe the approach, which ...
    ... Reinberg HealthDay Reporter , WEDNESDAY, Nov. 17 ... in some adult vaccination rates, U.S. health officials reported ... should be. "We needed vaccinations as infants and ... Susan J. Rehm, medical director of the National Foundation ...
    ... mysterious culprit that threatens headaches, stuffy noses, skin rash ... people worldwide drink wine. The discovery could help winemakers ... and whites with less potential to trigger allergy symptoms, ... Journal of Proteome Research . Giuseppe ...
    Cached Medicine News:Health News:New insight into the cause of common dementia found by researchers at Mayo Clinic 2Health News:New insight into the cause of common dementia found by researchers at Mayo Clinic 3Health News:Neuralstem files FDA application for first drug therapy 2Health News:Nerve Zap to Kidneys Might Ease Stubborn Hypertension 2Health News:Nerve Zap to Kidneys Might Ease Stubborn Hypertension 3Health News:CDC Report Finds Adult Vaccination Rates Still Lagging 2Health News:CDC Report Finds Adult Vaccination Rates Still Lagging 3
    40-well gradient cycler...
    ... a high quality, compact thermal cycler. In addition ... Mastercycler personal offers first-rate operational flexibility. Its universal ... x 0.2 ml tubes, 16 x 0.5 ml ... grid format. Like the Mastercycler and the Mastercycler ...
    ... instrument and custom filter wheels with ... The standard filter set includes: FAM/SYBR ... Red (585nm-610nm), Cy5 (635nm-665nm) and Cy3 ... Mx3005P analysis software, Beacon Designer oligo ...
    ... The system includes: Mx3005P instrument and ... of five (5) filters. The standard ... (492nm-516nm), HEX/JOE/VIC (535nm-555nm), ROX/Texas Red (585nm-610nm), ... included: desktop computer, Mx3005P analysis software, ...
    Medicine Products: